TP53 and neoplasm: A study was using the markers that reflect aggressive tumor characteristics, such as vascularization, P53 overexpression, and biliary/stem cell markers, and found it seems adequate to the reality with effects in OS, feasible in biopsies, which may identify patients that could benefit from aggressive treatments [34].